Pancreatic Cancer Research

ResearcherRenmin Hospital of Wuhan UniversityActive in the last 2 years

Wei Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-1749-9103; OpenAlex author ID A5100723250. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. Curcumin inhibits the invasion and migration of pancreatic cancer cells by upregulating TFPI-2 to regulate ERK- and JNK-mediated epithelial-mesenchymal transit… Co-author DOI 10.1007/s00394-023-03296-5↗
  2. N6 -methyladenosine RNA demethylase FTO regulates extracellular matrix-related genes and promotes pancreatic cancer cell migration and invasion. Co-author DOI 10.1002/cam4.5054↗
  3. m6A RNA demethylase FTO promotes the growth, migration and invasion of pancreatic cancer cells through inhibiting TFPI-2. Co-author DOI 10.1080/15592294.2022.2061117↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Lulu Zhai · 3 shared papers, 2022–2024 · strength 0.62
  2. Long-Jiang Chen · 2 shared papers, 2022–2024 · strength 0.42
  3. Zhi‐Gang Tang · 2 shared papers, 2022–2023 · strength 0.36
  4. Lichao Yao · 2 shared papers, 2022–2023 · strength 0.36
  5. Lun Wu · 2 shared papers, 2022–2023 · strength 0.36
  6. Tong-Fa Ju · 1 shared paper, 2024 · strength 0.26
  7. Dalong Yin · 1 shared paper, 2024 · strength 0.26
  8. Kaihuan Yu · 1 shared paper, 2023 · strength 0.19
  9. Jinzhuo Ning · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.